<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2024/Nevro-Third-Quarter-2024-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-11T04:06:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2024/Nevro-Second-Quarter-2024-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-06T04:07:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2024/Nevro-First-Quarter-2024-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:07:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2024/Nevro-Fourth-Quarter-2023-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-21T04:11:25-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2023/Nevro-Third-Quarter-2023-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T04:25:14-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2023/Nevro-Second-Quarter-2023-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T04:06:17-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2023/Nevro-First-Quarter-2023-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-26T04:54:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2023/-Nevro-Announces-Launch-of-Revolutionary-HFX-iQTM-Spinal-Cord-Stimulation-SCS-System/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-03-07T07:04:16-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2023/Nevro-Fourth-Quarter-2022-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-04T05:11:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2023/Nevro-Investor-Presentation--Jan-9-2023/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-09T06:02:05-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2022/Nevro-Third-Quarter-2022-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-11-02T04:09:58-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2022/Nevro-HFX-Patient-Testimonial-Video/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-06-07T04:07:02-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2022/Revolutionizing-the-Treatment-of-Painful-Diabetic-Neuropathy-PDN-with-High-Frequency-10-kHz-Spinal-Cord-Stimulation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-06-07T04:07:02-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2022/4Q-and-Full-Year-2021-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-06-13T12:31:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2021/Nevro-Investor-Presentation--Nov-29-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-29T11:05:58-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2021/Nevro-Third-Quarter-2021-Earnings-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-08T04:10:28-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2021/Nevro-Investor-Presentation--Apr-5-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-05T11:05:40-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2021/Nevro-Fourth-Quarter-2020-Investor-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-03-15T07:48:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2020/NANS-2020-Briefing/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-01-28T04:36:34-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2020/Nevro-At-JP-Morgan-38th-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-02-03T05:05:20-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2019/Nevro-First-Quarter-2019-Investor-Presentation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-03-15T07:48:04-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2019/Nevro-At-The-JP-Morgan-37th-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2017/Nevro-At-The-William-Blair-2017-Growth-Stock-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2017/Nevro-At-The-35th-Annual-JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2016/Nevro-At-The-Goldman-Sachs-37th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2016/Nevro-At-The-Bank-Of-America-Merrill-Lynch-2016-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2016/Nevro-At-The-JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/presentations/presentation-details/2015/Nevro-At-The-JMP-Securities-Life-Sciences-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2019-12-18T11:28:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2025/Nevro-Fourth-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-03-04T04:18:14-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/Nevro-Third-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-11T04:06:23-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/Wells-Fargo-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-28T04:15:31-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/Nevro-Second-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-06T04:07:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/Truist-Securities-2024-MedTech-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-11T04:15:45-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/BofA-Securities-2024-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-09T04:55:47-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/Nevro-First-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:07:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/Nevro-Fourth-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-21T04:11:25-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2024/JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-11T07:30:36-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Nevro-Third-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-03T10:03:10-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Morgan-Stanley-21st-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-23T03:24:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Wells-Fargo-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-23T03:24:11-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Canaccord-Genuity-43rd-Annual-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-29T10:27:54-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Nevro-Second-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T04:06:17-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Jefferies-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-12T09:16:13-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/2023-RBC-Capital-Markets-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-05-19T03:01:46-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/JMP-Securities-Life-Sciences-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-05-19T03:01:49-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Bank-of-America-2023-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-25T12:08:38-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Nevro-First-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-27T09:14:04-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Wells-Fargo-2023-Medtech-Innovation-Spotlight-Call-Series/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-04T12:53:50-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Citis-2023-Healthcare-Services-Medtech-Tools--HCIT-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-03-05T06:49:33-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/Nevro-Fourth-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-17T01:39:35-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2023/JP-Morgan-41st-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-10T01:08:00-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Nevro-Third-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-11-02T10:47:51-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Morgan-Stanley-20th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-09-13T04:45:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/-Wells-Fargo-2022-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-09-10T11:12:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Canaccord-Genuity-42nd-Annual-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-08-12T08:10:51-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Nevro-Second-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-08-03T09:49:26-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Nevro-At-BofA-Securities-2022-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-05-15T01:29:32-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/-Q1-2022-Earnings-Call/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-05-05T02:20:26-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Wells-Fargo-2022-MedTech-RD-Spotlight-Call-Series/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-03-07T11:13:21-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Nevro-At-Citis-2022-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-02-26T02:12:37-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Nevro-Fourth-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-02-24T05:03:19-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2022/Nevro-At-JP-Morgan-40th-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-11T12:00:19-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Piper-Sander-33rd-Annual-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-22T10:00:03-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-Third-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-09T01:21:24-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Baird-2021-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-10-15T02:38:51-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Morgan-Stanley-19th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-10-15T01:43:13-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Wells-Fargo-2021-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-10-15T01:26:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-Second-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-08-09T08:23:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-to-Host-Virtual-Investor-Briefing-from-ADA/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-06-11T12:29:05-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-at-UBS-Global-Healthcare-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-05-25T01:54:58-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/BofA-Securities-Virtual-2021-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-05-25T01:09:19-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-First-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-06-17T11:56:27-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-at-SVB-Leerink-10th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-03-03T01:21:47-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-at-Citis-2021-Healthcare-Services-Medtech-Tools--HCIT-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-03-03T01:21:47-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-Fourth-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-03-24T10:16:59-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-to-Host-Virtual-Investor-Briefing-at-2021-North-American-Neuromodulation-Society-NANS-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-06-24T07:23:48-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2021/Nevro-At-JP-Morgan-39th-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-03-03T08:50:19-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Citi-Banks-Head-Shoulders-Knees-and-Toes-Conference-Call/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T12:25:26-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Nevro-Third-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Morgan-Stanley/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Wells-Fargo/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-09-25T09:02:45-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Canaccord-Genuity-40th-Annual-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-09-01T03:15:08-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Nevro-Second-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/UBS-Virtual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/BofA-Securities-2030-Virtual-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Nevro-First-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Nevro-Fourth-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/NANS-2020-Briefing/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/event-details/2020/Nevro-At-JP-Morgan-38th-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-04T05:42:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2025/Globus-Medical-completes-acquisition-of-Nevro-Corp-/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-04-03T02:27:08-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2025/Nevro-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-03-04T04:19:08-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2025/Globus-Medical-to-Acquire-Nevro-Corp.to-Expand-Treatment-Options-for-Patients/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-02-06T11:50:29-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2025/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-01-21T04:30:36-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2025/Nevro-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2024-Revenue-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2025-01-13T08:31:16-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-a7dfcc244/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-17T04:30:29-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/New-Study-Demonstrates-Multiple-Advantages-of-Nevro1-the-Novel-SI-Joint-Fusion-System-by-Nevro-in-Comparison-to-Posterolateral-and-Lateral-Approaches/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-18T08:30:43-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-2c8816939/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-15T08:30:55-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevros-HFX-iQ-Spinal-Cord-Stimulation-with-AI-Technology-Receives-CE-Mark-Certification-in-Europe-Increasing-Product-Expansion-Globally/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-12T07:02:53-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Reports-Third-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-11-11T04:05:43-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/New-Data-Demonstrates-Long-Term-Improvements-in-Pain-Intensity-with-Nevros-High-Frequency-Spinal-Cord-Stimulation-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-10-29T04:30:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-e2265df93/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-10-16T04:30:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Report-Third-Quarter-2024-Financial-Results-and-Host-Earnings-Conference-Call-on-November-11-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-10-10T04:45:31-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-the-Launch-of-HFX-AdaptivAI-the-Only-AI-Driven-Technology-in-Spinal-Cord-Stimulation/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-24T08:03:05-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-2ff2dd302/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-09-19T04:30:39-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Present-at-Wells-Fargo-2024-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-28T04:15:20-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-ed68e0865/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-14T04:30:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Reports-Second-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-08-06T04:06:36-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-9f51b53e7/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-07-11T04:15:25-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Report-Second-Quarter-2024-Financial-Results-and-Host-Earnings-Conference-Call-on-August-6-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-07-09T04:15:35-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08-b4c0df6ea/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-28T08:30:49-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Present-at-Truist-Securities-MedTech-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-06-11T04:15:30-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-New-Employee-Inducement-Grants-Under-NYSE-Rule-303A.08/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-24T04:15:18-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Present-at-BofA-Securities-2024-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-09T04:06:32-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Reports-First-Quarter-2024-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Report-First-Quarter-2024-Financial-Results-and-Host-Earnings-Conference-Call-on-May-7-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-17T08:30:50-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Receives-FDA-510k-Clearance-to-Use-SI-Fixation-System-Without-Need-to-Include-Lateral-Screw/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-28T04:10:14-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Enters-Into-Cooperation-Agreement-With-Engaged-Capital/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-21T04:06:16-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-21T04:13:14-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-Consensus-Statement-Supporting-High-Frequency-10-kHz-Spinal-Cord-Stimulation-Therapy-for-Refractory-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-02-01T04:30:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Host-Conference-Call-on-February-21-2024/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-29T04:30:25-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-Positive-Coverage-Update-from-Carelon-Healthcare-for-the-Treatment-of-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-18T04:15:35-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Highlight-25-Scientific-Abstracts-at-2024-North-American-Neuromodulation-Society-NANS-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-17T04:15:20-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2023-Revenue-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-09T08:31:04-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2024/Nevro-to-Present-at-42nd-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-01-04T04:15:33-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Acquisition-of-Vyrsa-Technologies/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-30T05:19:51-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Delivers-Long-Term-Relief-with-High-Frequency-Spinal-Cord-Stimulation-24-Month-Data-Demonstrates-Profound-Improvements-for-Non-Surgical-Refractory-Back-Pain/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-20T07:01:19-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Reports-Third-Quarter-2023-Financial-Results-Provides-Fourth-Quarter-Guidance-and-Updates-Full-Year-2023-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T04:01:46-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Report-Third-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-10-04T07:02:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/New-Data-Demonstrate-the-Health-Economic-Benefits-of-Nevros-High-Frequency-Spinal-Cord-Stimulation-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-09-18T07:01:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Participation-in-Upcoming-Investor-Conferences-e394e4f52/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-23T07:01:16-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/New-24-Month-Data-Shows-Nevros-SCS-Therapy-Provides-Highly-Effective-Long-Term-Relief-from-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-16T07:01:10-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Reports-Second-Quarter-2023-Financial-Results-Provides-Third-Quarter-Guidance-and-Updates-Full-Year-2023-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-08-01T04:03:23-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Presentations-at-American-Society-of-Pain--Neuroscience-Fifth-Annual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-13T07:01:26-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Present-at-the-Canaccord-Genuity-43rd-Annual-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-07-12T07:00:50-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Report-Second-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-27T07:02:19-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Painful-Diabetic-Neuropathy-Clinical-Data-Presentations-at-the-American-Diabetes-Association-83rd-Scientific-Sessions/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-23T07:00:42-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Names-New-Chief-Commercial-Officer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-05T04:05:56-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Present-at-Jefferies-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-05-22T07:01:26-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Corp.-Announces-New-Employment-Inducement-Grant-under-Section-303A.08-of-the-NYSE-Listed-Company-Manual/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-27T04:06:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Reports-First-Quarter-2023-Financial-Results-Provides-Second-Quarter-Guidance-and-Reiterates-Full-Year-2023-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-26T04:07:35-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Enrollment-of-First-Patient-in-PDN-Sensory-Study/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-24T05:03:58-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Participation-in-Upcoming-Investor-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-24T07:01:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Names-Kevin-Thornal-as-New-Chief-Executive-Officer-and-President/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-19T05:05:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Report-First-Quarter-2023-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-03-29T07:01:32-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-U.S.-Full-Market-Launch-of-Revolutionary-HFX-iQ-Spinal-Cord-Stimulation-System-to-Personalize-Treatment-of-Chronic-Pain/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-03-07T07:03:06-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Participate-in-Wells-Fargo-2023-Medtech-Innovation-Spotlight-Call-Series/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-23T04:06:27-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-First-Quarter-and-Complete-Full-Year-2023-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-16T04:06:36-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Present-at-Citis-2023-Healthcare-Services-Medtech-Tools--HCIT-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-01T07:02:46-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Named-to-2023-Bloomberg-Gender-Equality-Index-for-Second-Consecutive-Year/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-31T04:06:15-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-19T07:01:22-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-to-Highlight-New-Clinical-Evidence-at-the-2023-North-American-Neuromodulation-Society-NANS-26th-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-12T07:01:20-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2023/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2022-Revenue-and-Provides-Full-Year-2023-Revenue-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-09T06:01:04-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Present-at-41st-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-12-19T04:05:32-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-Two-Presentations-from-SENZA-PDN-and-SENZA-NSRBP-Clinical-Trials-Have-Been-Accepted-for-Late-Breaking-Abstract-Sessions-at-NANS-2023-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-12-14T07:01:53-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Reports-Third-Quarter-2022-Financial-Results-Narrows-Full-Year-2022-Guidance-and-Raises-Revenue-Contribution-from-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-11-02T04:07:45-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-FDA-Approval-of-HFX-iQ-Spinal-Cord-Stimulation-System-to-Personalize-the-Treatment-of-Chronic-Pain/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-10-12T06:13:43-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Comments-on-UnitedHealthcare-Medical-Coverage-Policy-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-10-10T07:01:18-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Report-Third-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-10-05T07:01:13-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-FDA-Approval-of-Costa-Rica-Manufacturing-Operations/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-10-04T04:05:47-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-American-Association-of-Clinical-Endocrinology-Clinical-Practice-Guideline-Has-Been-Updated-to-Include-High-Frequency-10-kHz-Spinal-Cord-Stimulation-to-Treat-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-10-03T07:01:42-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-Multiple-Positive-Coverage-Updates-for-the-Treatment-of-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-09-01T07:02:49-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-Participation-In-Upcoming-Investor-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-08-09T07:02:54-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Reports-Second-Quarter-2022-Financial-Results-Provides-Third-Quarter-2022-Guidance-and-Updates-Full-Year-2022-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-08-03T04:06:30-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-and-Boston-Scientific-Announce-the-Settlement-of-Their-Ongoing-Intellectual-Property-Litigations/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-08-01T07:02:16-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Present-at-the-Canaccord-Genuity-42nd-Annual-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-07-21T07:03:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Report-Second-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-07-06T07:02:07-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Newly-Released-Clinical-Data-Demonstrates-Substantial-Improvement-in-Overall-Health-Related-Quality-of-Life-in-Patients-with-Painful-Diabetic-Neuropathy-Treated-with-Nevro-HFX-Spinal-Cord-Stimulation-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-07-05T07:01:40-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Clinical-Data-Presented-at-American-Diabetes-Association-82nd-Scientific-Sessions-Reinforce-Significant-and-Durable-Benefits-of-Nevros-HFX-10-kHz-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-06-07T04:06:15-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-SENZA-PDN-Clinical-Data-Presentations-at-the-American-Diabetes-Association-82nd-Scientific-Sessions/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-05-31T04:06:16-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Reports-First-Quarter-2022-Financial-Results-Provides-Second-Quarter-2022-Guidance-and-Reiterates-Full-Year-2022-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-05-04T04:08:24-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Report-First-Quarter-2022-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-04-06T07:03:07-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-Positive-Medicare-Coverage-Update-from-Noridian-for-the-Treatment-of-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-03-07T04:06:03-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Provides-First-Quarter-and-Full-Year-2022-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-02-23T04:06:15-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Participate-in-Wells-Fargo-2022-MedTech-RD-Spotlight-Call-Series/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-02-18T07:01:06-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-Publication-of-12-Month-Data-from-SENZA-NSRBP-Randomized-Controlled-Trial-in-Journal-of-Neurosurgery-Spine/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-02-11T08:30:30-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Present-at-Citis-2022-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-31T07:02:54-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Named-to-2022-Bloomberg-Gender-Equality-Index/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-26T04:05:59-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Responds-to-Competitors-Announcement-of-FDA-Approval-for-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-25T07:02:55-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-to-Report-Fourth-Quarter-and-Full-Year-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-24T04:05:52-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-FDA-Approval-for-Expanded-Labeling-for-its-10-kHz-High-Frequency-Spinal-Cord-Stimulation-System-for-Treatment-of-Non-Surgical-Refractory-Back-Pain-NSRBP/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-19T07:02:15-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Clinical-Data-Presented-at-2022-North-American-Neuromodulation-Society-NANS-Annual-Meeting-Reinforce-Significant-and-Durable-Benefits-of-Nevros-10-kHz-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-18T07:03:40-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2021-Revenue/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-10T06:01:21-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2022/Nevro-Announces-UnitedHealthcare-Coverage-for-High-Frequency-10-kHz-Therapy-for-the-Treatment-of-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-01-04T07:03:16-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Settlement-of-IP-Litigation-with-Nalu-Medical/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-12-21T04:05:43-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/CORRECTING-AND-REPLACING----Nevro-to-Present-at-40th-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-12-20T07:02:54-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Three-Podium-Presentations-from-SENZA-PDN-and-SENZA-NSRBP-Clinical-Trials-Have-Been-Accepted-for-Late-Breaking-Abstract-Sessions-at-NANS-2022-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-12-13T07:02:35-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-40th-Annual-J.P.-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-12-10T07:00:44-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Two-Health-Economic-Poster-Presentations-at-the-International-Society-for-Pharmacoeconomics-and-Outcomes-Research-ISPOR-Europe-2021-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-30T07:02:48-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Three-Important-Clinical-Data-Publications-for-Treating-Painful-Diabetic-Neuropathy-with-10-kHz-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-29T11:05:17-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Reports-Third-Quarter-2021-Financial-Results-and-Provides-Fourth-Quarter-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-08T04:07:01-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Update-in-Patent-Litigation-with-Boston-Scientific/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-11-01T06:32:00-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-Piper-Sandler-33rd-Annual-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-10-25T06:00:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Report-Third-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-10-11T06:00:35-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Director-Appointment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-10-18T04:08:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-Baird-2021-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-08-26T06:00:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-Morgan-Stanley-19th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-08-25T06:00:37-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-Wells-Fargo-Virtual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-08-23T06:01:03-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Reports-Second-Quarter-2021-Financial-Results-and-Provides-Third-Quarter-of-2021-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-08-04T04:07:52-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-FDA-Approval-of-its-10-kHz-High-Frequency-Spinal-Cord-Stimulation-Therapy-for-Treatment-of-Chronic-Pain-Associated-with-Painful-Diabetic-Neuropathy-PDN/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-07-19T07:01:59-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Report-Second-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-07-07T07:02:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-SENZA-PDN-Clinical-Data-Presentation-at-the-American-Diabetes-Association-81st-Scientific-Sessions/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-06-22T11:29:39-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-SENZA-NSRBP-Clinical-Data-Presentation-at-the-American-Society-of-Interventional-Pain-Physicians-23rd-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-06-22T11:29:39-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Host-Virtual-Analyst--Investor-Briefing/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-06-22T03:17:13-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Reports-First-Quarter-2021-Financial-Results-and-Updates-2021-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-05-18T04:38:36-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-UBS-Global-Healthcare-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-27T07:02:53-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Introduces-HFX-New-Comprehensive-Brand-Identity-Combining-Nevros-Innovative-Technologies-Advanced-Therapies-and-End-to-End-Patient-Support/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-27T03:46:22-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Appoints-Jon-R.-Shear-as-Vice-President-Corporate-Development/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-26T03:14:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-BofA-Securities-2021-Virtual-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-26T03:14:44-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Report-First-Quarter-2021-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-07T07:01:55-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Publication-Of-Landmark-SENZA-PDN-Clinical-Trial-Results-In-JAMA-Neurology/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-04-05T11:04:40-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-02-24T04:06:31-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-10th-Annual-SVB-Leerink-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-02-01T07:01:48-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Present-at-Citis-2021-Healthcare-Services-Medtech-Tools--HCIT-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-02-01T07:01:17-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-01-27T07:01:11-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Clinical-Data-Presented-at-2021-North-American-Neuromodulation-Society-NANS-Virtual-Meeting-Reinforce-Significant-Benefits-of-Nevros-HF10-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-01-19T07:02:20-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-to-Highlight-New-Clinical-Evidence-at-the-2021-North-American-Neuromodulation-Society-NANS-Virtual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-01-14T07:01:44-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2021/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2020-Revenue/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2021-01-11T07:02:09-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-FDA-Submission-for-HF10-Therapy-in-Patients-with-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-28T04:08:36-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Host-Virtual-Investor-Briefing-at-2021-North-American-Neuromodulation-Society-NANS-Virtual-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-22T04:05:30-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Present-at-39th-Annual-J.P.-Morgan-Healthcare-Conference-on-Tuesday-January-12-2021/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-15T04:05:33-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Agreement-to-Conclude-Its-Patent-Lawsuit-in-the-Northern-District-of-California-Against-Boston-Scientific/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-14T04:30:30-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Director-Appointment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-12-03T07:01:48-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Appoints-Julie-D.-Dewey-as-Vice-President-Investor-Relations-and-Corporate-Communications/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-11-30T07:00:32-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Participate-in-Citi-Bank-Head-Shoulders-Knees-and-Toes-Conference-Call-Series-on-November-30th/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-11-24T07:01:40-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Abstract-Presentations-for-PDN-and-NSRBP-Trials-Have-Been-Accepted-for-the-Late-Breaking-Trials-Plenary-Session-at-NANS-2021-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-11-17T04:02:16-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Third-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-11-05T04:02:30-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Report-Third-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-10-22T04:05:48-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Initiates-Plan-for-Manufacturing-Operations-in-Costa-Rica-to-Support-Future-Growth/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-09-14T07:02:28-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Present-at-Upcoming-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-09-01T07:01:18-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Present-at-Canaccord-Genuity-40th-Annual-Virtual-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-08-07T07:01:19-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Second-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-08-05T04:11:21-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Report-Second-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-07-20T07:00:35-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Appoints-Finance-Executive-Roderick-MacLeod-as-Chief-Financial-Officer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-06-19T07:09:59-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Reports-First-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-To-Participate-in-Upcoming-May-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Report-First-Quarter-2020-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Federal-Circuit-Rules-in-its-Favor-and-Upholds-the-Validity-of-Nevros-Patent-Claims-In-Its-Litigation-Against-Boston-Scientific/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-the-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Common-Stock-and-the-Underwriters-Over-allotment-Option-to-Purchase-Additional-Convertible-Senior-Notes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Pricing-of-Public-Offerings-of-Common-Stock-and-Convertible-Senior-Notes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Proposed-Public-Offering-of-Common-Stock-and-Convertible-Senior-Notes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Provides-First-Quarter-and-FY2020-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-and-Stimwave-Reach-Worldwide-Settlement-in-Patent-Infringement-Lawsuit-Stimwave-Agrees-to-a-Permanent-Injunction/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Files-Lawsuit-for-Patent-Infringement-Against-Nalu-Medical-in-the-US/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Report-Fourth-Quarter-and-Full-Year-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Present-New-Clinical-Evidence-at-the-23rd-Annual-North-American-Neuromodulation-NANS-Society-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Names-Donald-A-Middlebrook-to-Lead-Clinical-Regulatory-and-Quality/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2019-Revenue/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2020/Nevro-to-Host-Investor-Briefing-at-North-American-Neuromodulation-Society-NANS-2020-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Present-at-the-38th-Annual-JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Appoints-Karen-N-Prange-to-the-Companys-Board-of-Directors/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Reports-Third-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Report-Third-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Announces-Completion-of-Patient-Enrollment-in-Largest-Multicenter-Randomized-Controlled-Trial-of-High-Frequency-Spinal-Cord-Stimulation-for-Painful-Diabetic-Neuropathy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Present-at-Morgan-Stanley-17th-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Reports-Second-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Announces-Court-Order-Granting-Preliminary-Injunction-Against-Stimwave-Technologies-Inc/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Report-Second-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Announces-Executive-Appointments/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Present-at-BMO-2019-Prescriptions-for-Success-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Highlight-Substantial-Body-of-Clinical-Evidence-Supporting-Expanded-Applications-and-Unique-Capabilities-of-HF10-Therapy-at-the-14th-International-Neuromodulation-Society-World-Congress/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Names-D-Keith-Grossman-Chairman-of-the-Board-Michael-DeMane-as-Lead-Director/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Reports-First-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Present-at-the-Bank-of-America-Merrill-Lynch-Healthcare-Conference-2019/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Report-First-Quarter-2019-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Announces-New-CEO-Board-Appointments-and-Agreement-with-Broadfin-Capital/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Reports-Fourth-Quarter-and-Full-Year-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Files-Lawsuit-for-Patent-Infringement-Against-Stimwave-in-the-US/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-to-Report-Fourth-Quarter-and-Full-Year-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2018-Revenue/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Present-at-the-37th-Annual-JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Reports-Third-Quarter-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Report-Operating-Results-for-the-Third-Quarter-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Receives-TGA-Approval-for-Senza-IITM-Spinal-Cord-Stimulation-System-Delivering-HF10TM-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Present-at-the-Morgan-Stanley-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Reports-Second-Quarter-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Announces-Patent-Litigation-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Announces-Patent-Litigation-Update-20180725000000/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Report-Operating-Results-for-the-Second-Quarter-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Announces-Preliminary-Unaudited-Second-Quarter-2018-Revenue-and-Updates-Full-Year-2018-Revenue-Guidance/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Announce-Preliminary-Second-Quarter-Worldwide-Revenue-Discuss-Full-Year-2018-Revenue-Guidance-and-Provide-Business-Updates/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Recognized-as-a-Best-Place-to-Work-in-the-Bay-Area/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Reports-First-Quarter-2018-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Present-at-the-Bank-of-America-Merrill-Lynch-2018-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Report-Operating-Results-for-the-First-Quarter-2018/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Full-Body-MRI-Conditional-Labeling-Now-Available-in-United-States-for-Nevro-Senza-Spinal-Cord-Stimulation-System/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Reports-Fourth-Quarter-and-Full-Year-2017-Financial-Results-and-Provides-2018-Outlook/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Report-Operating-Results-for-the-Fourth-Quarter-and-Full-Year-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-to-Highlight-Body-of-Clinical-Evidence-Supporting-Expanded-Use-and-Potential-New-Indications-of-Companys-Senza-Spinal-Cord-Stimulation-Systems-Delivering-HF10-Therapy-at-NANS-Annual-Meeting/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Receives-FDA-Approval-for-Senza-II-Spinal-Cord-Stimulation-System-Delivering-HF10-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2018/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Fiscal-Year-2017-Revenue/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Present-at-the-36th-Annual-JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Receives-CE-Mark-for-Senza-II-Spinal-Cord-Stimulation-System-Delivering-HF10-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Receives-CE-Mark-for-Full-Body-MRI-Conditional-Labeling-with-the-Senza-Spinal-Cord-Stimulation-System/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Reports-Third-Quarter-2017-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Report-Operating-Results-for-the-Third-Quarter-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Present-at-Upcoming-Investor-Conferences/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Reports-Second-Quarter-2017-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Present-at-the-Canaccord-Genuity-Growth-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Report-Operating-Results-for-the-Second-Quarter-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Announces-Preliminary-Unaudited-Second-Quarter-2017-Revenue-and-Business-Update/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/EY-Announces-Rami-Elghandour-President-and-CEO-of-Nevro-as-2017-Entrepreneur-Of-The-Year/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Neurosurgery-Selects-the-SENZA-RCT-24-Month-Outcomes-Publication-as-the-Top-Pain-Paper-of-the-Year/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Present-at-the-William-Blair-Growth-Stock-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Reports-First-Quarter-2017-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Present-at-the-Bank-of-America-Merrill-Lynch-2017-Health-Care-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Report-Operating-Results-for-the-First-Quarter-2017/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-Reports-Fourth-Quarter-and-Full-Year-2016-Financial-Results-and-Provides-2017-Outlook/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Nevro-to-Report-Operating-Results-for-the-Fourth-Quarter-and-Full-Year-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-the-35th-Annual-JP-Morgan-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Announces-Filing-of-Lawsuit-by-Boston-Scientific/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Files-Lawsuit-for-Patent-Infringement-Against-Boston-Scientific-in-the-US/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-the-28th-Annual-Piper-Jaffray-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Reports-Third-Quarter-2016-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Report-Operating-Results-for-the-Third-Quarter-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Publication-of-Two-Year-SENZA-RCT-Results-in-Neurosurgery-Demonstrates-Sustained-Superiority-of-HF10-Therapy-over-Traditional-Spinal-Cord-Stimulation-for-Chronic-Pain/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-Upcoming-Investor-Conferences-20160825000000/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Reports-Second-Quarter-2016-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Report-Operating-Results-for-the-Second-Quarter-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Announces-Full-Exercise-of-Over-Allotment-Option-and-Closing-of-Public-Offering-of-1725-Million-Convertible-Senior-Notes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-the-JMP-Securities-Life-Sciences-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Announces-Pricing-of-Public-Offering-of-150-Million-Convertible-Senior-Notes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Announces-Proposed-Public-Offering-of-125-Million-Convertible-Senior-Notes/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-Goldman-Sachs-37th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Reports-First-Quarter-2016-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-Bank-of-America-Merrill-Lynch-2016-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Report-Operating-Results-for-the-First-Quarter-2016/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Receives-FDA-Approval-for-New-Surgical-Leads-for-the-Senza-Spinal-Cord-Stimulation-System-Delivering-HF10-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Reports-Fourth-Quarter-and-Full-Year-2015-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Announces-Executive-Succession/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Report-Operating-Results-for-the-Fourth-Quarter-and-Full-Year-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-to-Present-at-the-Leerink-Partners-5th-Annual-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2016/Nevro-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Fiscal-Year-2015-Revenue/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Present-at-the-JP-Morgan-34th-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/CMS-Approves-Transitional-Pass-Through-Payment-for-Outpatient-Use-of-Nevros-Senza-Spinal-Cord-Stimulation-System/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-the-US-Patent-and-Trademark-Offices-Denial-of-Boston-Scientific-Petitions-for-Inter-Partes-Review-of-US-Patent-No-8359102/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Reports-Third-Quarter-2015-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Report-Operating-Results-for-the-Third-Quarter-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Present-at-the-Morgan-Stanley-Global-Healthcare-Conference-20150903000000/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-Submission-of-Preliminary-Response-to-the-Patent-Trial-and-Appeals-Board/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Reports-Second-Quarter-2015-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-Publication-of-SENZA-RCT-Results-in-Anesthesiology/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Report-Operating-Results-for-the-Second-Quarter-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Appoints-Lisa-Earnhardt-to-its-Board-of-Directors/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-Full-Exercise-and-Closing-of-Underwriters-Option-to-Purchase-Additional-Shares/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Present-at-the-JMP-Securities-Life-Sciences-Conference-20150610000000/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-Proposed-Public-Offering-of-Common-Stock/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-First-Commercial-Procedure-of-HF10-Therapy-in-the-United-States/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Files-S-1-Registration-Statement-for-Proposed-Primary-and-Secondary-Public-Offering/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Announces-Filing-of-Petitions-for-Inter-Partes-Review-of-US-Patent-No-8359102/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Reports-First-Quarter-2015-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Receives-FDA-Approval-for-Senza-Spinal-Cord-Stimulation-System-Delivering-HF10-Therapy/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Report-Operating-Results-for-the-First-Quarter-2015/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Reports-Fourth-Quarter-and-Full-Year-2014-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Report-Operating-Results-for-the-Fourth-Quarter-and-Full-Year-of-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Appoints-Dr-Brad-Vale-to-its-Board-of-Directors/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Receives-Expanded-MR-Conditional-Labeling-for-Senza-Spinal-Cord-Stimulation-System-in-Europe-and-Australia/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-to-Present-at-the-2015-Leerink-Global-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2015/Nevro-Receives-Approvable-Letter-from-US-Food-and-Drug-Administration-for-Senza-Spinal-Cord-Stimulation-System/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-to-Present-at-the-JP-Morgan-33rd-Annual-Healthcare-Conference/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Announces-First-Draw-Down-of-20-Million-Under-Term-Loan-Facility-with-CRG/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Reports-Third-Quarter-Financial-Results/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-to-Report-2014-Third-Quarter-Financial-Results-and-Host-Conference-Call-on-December-2-2014/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Corp-Announces-Full-Exercise-of-Over-Allotment-Option-and-Closing-of-Initial-Public-Offering/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Corp-Announces-Pricing-of-Initial-Public-Offering/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Announces-Issuance-of-Key-European--Australian-Patents-for-Innovative-Chronic-Pain-Treatment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Strengthens-Leadership-Team-with-the-Appointment-of-David-Caraway-MD-PhD-as-Chief-Medical-Officer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2014/Nevro-Corp-Announces-Publication-of-24-month-European-Clinical-Data-on-HF10-Spinal-Cord-Stimulation-SCS-Therapy-for-Chronic-Back-and-Leg-Pain/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2013/Nevro-Corp-Completes-Enrollment-of-US-Randomized-Pivotal-Trial-of-Novel-Chronic-Pain-Treatment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2013/Nevro-Corp-Closes-48-Million-in-New-Financing/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2013/Nevro-Corp-Announces-Publication-of-Positive-Six-Month-Clinical-Data-for-Senza-HF10-High-Frequency-Spinal-Cord-Stimulation-Therapy-in-Europe/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2013/Nevro-Announces-Issuance-of-Additional-Key-US-Patents-for-Innovative-Chronic-Pain-Treatment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2012/FierceMedicalDevices-Names-Nevro-Corp-as-one-of-its-Fierce-15-Medical-Device-and-Diagnostic-Companies-of-2012/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2012/First-Patient-Treated-in-Landmark-US-Randomized-Pivotal-Trial-of-Nevros-Chronic-Pain-Treatment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2012/Nevro-Announces-Issuance-of-Key-US-Patents-for-Innovative-Chronic-Pain-Treatment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2012/Nevro-Receives-FDA-Approval-to-Initiate-Landmark-US-Randomized-Pivotal-Trial-of-Innovative-Chronic-Pain-Treatment/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2011/Nevro-Corp-Closes-58-Million-in-New-Financing/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/investors/investor-news/investor-news-details/2011/Nevro-Appoints-Michael-DeMane-President-and-Chief-Executive-Officer/default.aspx</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2020-05-14T06:30:34-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=03b61eb4-6ef5-4ff2-a073-b741b9d1038b</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-10T04:14:08-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=bb324ca3-09fc-4fcb-a196-1908875b659b</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-12-01T02:22:10-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=ae2fb2f1-e62e-47f9-bf28-27e80c8ba928</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=5d1d6473-352c-48af-b8e0-4ea66706c188</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=233ac8ee-569d-4412-9f61-ba13d0deb27d</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-08-26T03:46:52-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=646fc12f-ac85-4492-b190-97bd70278816</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-24T04:00:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=ac09d9f8-2609-490c-a8ef-8faebccb48e2</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-27T02:13:09-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=4ad5838c-4b4f-40b4-96ff-ad0594499945</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=99ac3b00-c603-4c95-b27f-4fcc28482e0f</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=1b8f3556-b458-4a95-af51-f5fcf36fb823</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-04-24T04:00:09-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=ede4a692-fd29-4071-867a-db1e87752d72</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=888ba868-7e23-4365-8f20-741cd4201a8d</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=e77c8b8b-b83a-4467-9b63-9089dbe4d0b9</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=e1f6351c-e564-4831-8618-f154d9b68727</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T07:34:51-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=a5a31fd7-6b42-43e1-9597-48cadeef90b9</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=5f59e434-40cd-47b0-9a45-c63511e4102f</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=8cac1172-7320-45ce-984a-072cfe370b37</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=dee8ddb8-dc77-4c87-8c08-2db4a58969ff</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-27T02:13:09-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=da2d8615-3922-42ca-aae3-15392d1d1a77</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-19T06:32:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=8c4d9c78-9710-4602-be4b-930626e5e45e</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-19T06:32:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=a1edd319-85ac-4be3-a5b5-32ad44f3b39c</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2022-09-30T09:25:50-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=8f0ce8d4-b28e-4815-acc0-b6791a793bac</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=86d757b3-1ded-47cb-a602-76c87c1614eb</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=d57ac782-cb82-4570-9bbf-4fbf783a35c3</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-04-12T12:21:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=02ac1841-6b9a-4ce1-bf08-9f104458a590</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=1f9cd27f-792b-45a4-9ded-7486bb18977a</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=1daa5920-d586-41e9-a62a-899965a89bb2</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=e88cd95d-d6bd-4d65-8249-a45bab87b51f</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-19T06:32:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=1f75ae26-42ca-4b7d-b336-5c55966fdf64</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-19T06:32:33-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=de860ff2-7f52-4ec9-9f87-7b8bc981559d</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=35f91506-e199-4460-af30-ac4eb2c6a8be</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=0c1c336d-7785-4cf6-a15c-fb93425ff3e0</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-06-15T12:53:41-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=fca41b97-4adf-4257-b60a-8fdbad36b4ca</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=cba3e99f-7383-41f0-b3c8-956df94280c3</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=e7a17af6-ff39-498c-8ba6-81bbd8af81d1</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-12-05T09:23:56-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=f0568354-facf-4610-a39b-0daa3624d2bb</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=75e84724-c00c-4aa0-b14b-cdad665efd84</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-07T04:06:12-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=ffec5941-3be5-40f9-a3be-e94683fd1056</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=5bb7693c-5a40-498a-a047-8ec1eb8b25ef</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-01-27T10:39:30-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=4b2394de-20e6-439c-971e-eac61404eae8</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-02-23T07:08:10-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=f8977cb7-c87c-4e50-8429-355bb70d0ed9</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-11-01T12:10:06-04:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=43726d90-11bd-4ef4-897b-3ccb12b034fa</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2023-12-01T02:22:10-05:00</lastmod>
  </url>
  <url>
    <loc>https://intl.nevro.com/English/us/about/leadership-team/person-details/default.aspx?ItemId=038fc22b-d70a-4048-9a8b-88186c7f6533</loc>
    <changefreq>hourly</changefreq>
    <lastmod>2024-05-14T03:34:43-04:00</lastmod>
  </url>
</urlset>